Shareholders to Vote on Redesigned Executive Pay, Increased Director Fees After Prior Dissent
JHX sits 51% above its 52-week low of $16.46.
Summary
James Hardie Industries plc is presenting a redesigned executive compensation plan and a significant increase to the non-executive director fee pool for shareholder approval, directly responding to prior shareholder rejection of its remuneration report.
Key Events · Corporate Governance and Compliance · JHX
-
Redesigned Executive Compensation Program
The company has overhauled its FY27 executive compensation program, reducing cash-settled long-term incentives, capping maximum payouts at 200% of target, and introducing stock options, in direct response to shareholder feedback and the rejection of the FY25 remuneration report.
-
CEO Equity Grant Proposal
Shareholders will vote on a binding proposal for the CEO's FY27 equity grant, totaling $6.1 million in PRSUs, RSUs, and stock options. This includes a one-time LTI award with a target value of $1 million as a partial replacement for a previously rejected FY26 ROCE PRSU award.
-
Increased Non-Executive Director Fee Pool
A binding proposal seeks to increase the maximum aggregate non-executive director compensation by $700,000 (an 18.4% increase) from $3.8 million to $4.5 million per annum, citing expanded duties, inflation, and the need to attract global talent.
-
Negative Discretion Applied to FY26 Payouts
The People & Compensation Committee exercised significant negative discretion to reduce FY26 short-term and long-term incentive payouts for the CEO and other NEOs, including the CEO's STI paying out at 48% of target, reflecting shareholder concerns despite strong performance early in the period.
Analysis · JHX · Manufacturing
This preliminary proxy statement outlines critical proposals for the upcoming Annual General Meeting, directly addressing significant shareholder dissatisfaction from the previous year's remuneration report vote. The company has redesigned its FY27 executive compensation program, including a substantial $6.1 million equity grant for the CEO (partially replacing a previously rejected award), and is seeking approval for an 18.4% increase in the non-executive director fee pool. These proposals, alongside the application of negative discretion to FY26 executive payouts, represent a material effort to realign executive incentives with shareholder interests and strengthen corporate governance following past dissent.
At the time of this filing, JHX was trading at $24.87 on NYSE in the Manufacturing sector, with a market capitalization of approximately $14.4B. The 52-week trading range was $16.46 to $29.83. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.